Versant Capital Management
MIRM icon

Versant Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Versant Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12.3K Buy
144
+74
+106% +$7.72K ﹤0.01% 2195
2026
Q2 		$8.2K Buy
70
+12
+21% +$1.2K ﹤0.01% 2290
2026
Q1 		$5.36K Hold
58
– – ﹤0.01% 2361
2025
Q4 		$4.58K Hold
58
– – ﹤0.01% 2285
2025
Q3 		$4.25K Buy
58
+54
+1,350% +$3.43K ﹤0.01% 2270
2025
Q2 		$204 Buy
+4
New +$178 ﹤0.01% 2595

Other funds holding MIRM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return

Versant Capital Management's MIRM Position: Q3 2026 in Review

Versant Capital Management increased its Mirum Pharmaceuticals (MIRM) stake by 106% in Q3 2026, buying an estimated $7.72K and bringing the position to 144 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2195.

Versant Capital Management first reported a position in MIRM in Q2 2025 and has held it in 6 quarters since. 172 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • Versant Capital Management held 144 shares of Mirum Pharmaceuticals worth $12.3K as of Q3 2026.
  • Versant Capital Management bought 74 Mirum Pharmaceuticals shares in Q3 2026, an estimated $7.72K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2195 holding.
  • Versant Capital Management first reported a position in Mirum Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
  • 172 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.